Published in Crit Care Med on April 01, 2013
Timing of antibiotics, volume, and vasoactive infusions in children with sepsis admitted to intensive care. Crit Care (2015) 0.95
Development of metabolic and inflammatory mediator biomarker phenotyping for early diagnosis and triage of pediatric sepsis. Crit Care (2015) 0.92
Neurologic complications and neurodevelopmental outcome with extracorporeal life support. World J Crit Care Med (2013) 0.89
On nontraumatic brain injury in pediatric critical illness, neuropsychologic short-term outcome, delirium, and resilience. Crit Care Med (2013) 0.85
Transforming PICU Culture to Facilitate Early Rehabilitation. J Pediatr Intensive Care (2015) 0.82
Management of neonatal sepsis in term newborns. F1000Prime Rep (2014) 0.76
Stress hormones and posttraumatic stress symptoms following paediatric critical illness: an exploratory study. Eur Child Adolesc Psychiatry (2016) 0.75
Sepsis After Cardiac Surgery Early in Infancy and Adverse 4.5-Year Neurocognitive Outcomes. J Am Heart Assoc (2015) 0.75
Pediatric sepsis. Curr Opin Pediatr (2016) 0.75
Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome. Pediatr Crit Care Med (2017) 0.75
Characteristics of postintensive care syndrome in survivors of pediatric critical illness: A systematic review. World J Crit Care Med (2017) 0.75
If You Build It, They Will Come: Initial Experience with a Multi-Disciplinary Pediatric Neurocritical Care Follow-Up Clinic. Children (Basel) (2017) 0.75
Grand challenges in global mental health. Nature (2011) 8.40
Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med (2009) 7.55
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci (2003) 5.94
Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99
The mental wealth of nations. Nature (2008) 3.60
Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev (2007) 3.51
Fluid overload at 48 hours is associated with respiratory morbidity but not mortality in a general PICU: retrospective cohort study. Pediatr Crit Care Med (2015) 2.73
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia (2003) 2.55
The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ (2005) 2.52
Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41
The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry (2002) 2.35
Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet (2010) 2.32
Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry (2011) 2.24
Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20
ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis. Pediatr Crit Care Med (2006) 2.19
Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17
Risk taking during decision-making in normal volunteers changes with age. J Int Neuropsychol Soc (2004) 2.12
A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex. Brain (2004) 2.11
Reflection impulsivity in current and former substance users. Biol Psychiatry (2006) 2.09
Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology (2003) 1.99
Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci (2009) 1.92
Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry (2006) 1.92
The neuropsychiatry of impulsivity. Curr Opin Psychiatry (2007) 1.90
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2003) 1.89
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry (2007) 1.82
Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain (2007) 1.81
Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology (2006) 1.81
Lifting the veil on trichotillomania. Am J Psychiatry (2007) 1.81
The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry (2011) 1.80
Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology (Berl) (2008) 1.79
Impulsivity and response inhibition in alcohol dependence and problem gambling. Psychopharmacology (Berl) (2009) 1.76
Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med (2003) 1.74
Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit. Eur J Pharmacol (2010) 1.74
Methylphenidate improves response inhibition but not reflection-impulsivity in children with attention deficit hyperactivity disorder (ADHD). Psychopharmacology (Berl) (2008) 1.71
Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry (2007) 1.71
The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol (2013) 1.62
Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med (2003) 1.61
White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry (2008) 1.60
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. Pediatrics (2004) 1.60
Emergency management of meningococcal disease: eight years on. Arch Dis Child (2007) 1.57
Functional neuroimaging of avoidance habits in obsessive-compulsive disorder. Am J Psychiatry (2014) 1.56
Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet (2004) 1.56
Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biol Psychiatry (2004) 1.56
Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. Am J Psychiatry (2012) 1.55
Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet (2009) 1.53
Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry (2004) 1.50
The effects of tryptophan depletion on neural responses to emotional words in remitted depression. Biol Psychiatry (2009) 1.50
Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology (2005) 1.49
The contributions of lesion laterality and lesion volume to decision-making impairment following frontal lobe damage. Neuropsychologia (2003) 1.48
Mood-congruent bias in affective go/no-go performance of unmedicated patients with major depressive disorder. Am J Psychiatry (2005) 1.48
Translational approaches to frontostriatal dysfunction in attention-deficit/hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry (2010) 1.45
Abdominal pain in British young people: associations, impairment and health care use. J Psychosom Res (2012) 1.44
Children's self-reported quality of life after intensive care treatment. Pediatr Crit Care Med (2013) 1.44
Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord (2003) 1.43
Cognitive mechanisms of treatment in depression. Neuropsychopharmacology (2011) 1.43
Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract. Life Sci (2010) 1.42
Problem gamblers share deficits in impulsive decision-making with alcohol-dependent individuals. Addiction (2009) 1.41
Persistent infection, inflammation, and functional impairment in older Latinos. J Gerontol A Biol Sci Med Sci (2008) 1.39
Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biol Psychiatry (2004) 1.38
Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage (2008) 1.37
Reward/Punishment reversal learning in older suicide attempters. Am J Psychiatry (2010) 1.36
Training general practitioners in the identification and management of adolescent depression within the consultation: a feasibility study. J Adolesc (2003) 1.34
Executive function in Tourette's syndrome and obsessive-compulsive disorder. Psychol Med (2005) 1.31
Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol Psychiatry (2007) 1.28
Neuro-cognitive performance in children with type 1 diabetes--a meta-analysis. J Pediatr Psychol (2008) 1.27
Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology (Berl) (2004) 1.24
Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology (2004) 1.23
Noradrenergic modulation of working memory and emotional memory in humans. Psychopharmacology (Berl) (2006) 1.22
Impairment in risk-sensitive decision-making in older suicide attempters with depression. Psychol Aging (2011) 1.21
Association between response inhibition and working memory in adult ADHD: a link to right frontal cortex pathology? Biol Psychiatry (2006) 1.18
Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. Arch Gen Psychiatry (2010) 1.17
Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev (2010) 1.16
The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychol Rev (2007) 1.15
The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers. Neuropsychopharmacology (2007) 1.15
Selected executive skills in adolescents with recent first episode major depression. J Child Psychol Psychiatry (2005) 1.15
Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology (2006) 1.14
A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania. Neuropsychologia (2006) 1.14
Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain (2003) 1.13
Subcutaneous emphysema of the neck in infancy: under-recognized presentation of child abuse. J Laryngol Otol (2004) 1.12
Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion. Neuropsychopharmacology (2006) 1.12
Could neonatal disseminated herpes simplex virus infections be treated earlier? J Infect (2004) 1.11
Prevalence of retinal hemorrhages in critically ill children. Pediatrics (2012) 1.11
The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention. Int J Neuropsychopharmacol (2006) 1.10
Reliance on habits at the expense of goal-directed control following dopamine precursor depletion. Psychopharmacology (Berl) (2011) 1.10
The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biol Psychiatry (2008) 1.10
The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls. Psychopharmacology (Berl) (2006) 1.10
The neuropsychology of mood disorders. Curr Psychiatry Rep (2006) 1.10
Task-set switching deficits in early-stage Huntington's disease: implications for basal ganglia function. J Cogn Neurosci (2003) 1.10
Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist. Biol Psychiatry (2011) 1.09
The role of the lateral frontal cortex in causal associative learning: exploring preventative and super-learning. Cereb Cortex (2004) 1.09
Visuospatial learning and executive function are independently impaired in first-episode psychosis. Psychol Med (2005) 1.08
The short-term outcome of depressive disorder in adolescents attending primary care: a cohort study. Soc Psychiatry Psychiatr Epidemiol (2010) 1.08
Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc Natl Acad Sci U S A (2014) 1.07
Hippocampal dysfunction in patients with mild cognitive impairment: a functional neuroimaging study of a visuospatial paired associates learning task. Neuropsychologia (2011) 1.07
Perturbations in electrolyte levels in kenyan children with severe malaria complicated by acidosis. Clin Infect Dis (2004) 1.07
Psychiatric outcome following paediatric intensive care unit (PICU) admission: a cohort study. Intensive Care Med (2004) 1.06